Abstract
Aims: Observational studies report inconsistent associations between moderate alcohol intake and blood pressure (BP). In a 6-month randomized controlled trial we assessed the effect of initiating moderate red wine consumption on 24h-dynamics BP, specific time-intervals of BP, and its interaction with a common genetic variant of alcohol-dehydrogenases (ADH) among patients with type-2-diabetes.
Methods:We randomly assigned 54 type-2-diabetes patients, alcohol abstainers, to initiate consumption of 150ml dry red-wine or mineral-water at dinner. Both groups were guided to adhere to Mediterranean diet, without caloric restriction. We measured 24h ambulatory-blood-pressure-monitoring (ABPM) and ADH1B polymorphism.
Results:Participants (age=57yrs;85% men;24h blood pressure=129/77mmHg) had 92% six-month retention. After 6-month intervention, average 24hr BP did not differ between the wine and water groups. The ABPM decreased in the red-wine group at midnight (3-4 hours after wine intake: systolic BP: red-wine=-10.6mmHg vs. mineral-water=+2.3mmHg; p=0.031) and the following morning at 7-9AM (systolic BP: red-wine:-6.2mmHg vs. mineral-water:+5.6mmHg; p=0.014). Among the red-wine consumers, only the individuals who were homozygous for the gene encoding ADH1B*2 variant (Arg48His;rs1229984,TT, fast ethanol metabolizers), exhibited a significant decrease in mean 24h systolic BP (-8.0mmHg vs. +3.7mmHg; p=0.002) and pulse pressure (-3.8mmHg vs. +1.2mmHg; p=0.032) compared to heterozygotes and homozygous for the ADH1B*1 variant (CC, slow metabolizers). No genetic interaction was observed for the water group.
Conclusions:Initiating moderate red-wine consumption at dinner in type-2-diabetics may have modest hypotensive effects within several hours after its consumption, and the following morning. The genetic interaction uncovers a personalized/precision-medicine factor regulating the hypotensive effect of red-wine in diabetes.
Methods:We randomly assigned 54 type-2-diabetes patients, alcohol abstainers, to initiate consumption of 150ml dry red-wine or mineral-water at dinner. Both groups were guided to adhere to Mediterranean diet, without caloric restriction. We measured 24h ambulatory-blood-pressure-monitoring (ABPM) and ADH1B polymorphism.
Results:Participants (age=57yrs;85% men;24h blood pressure=129/77mmHg) had 92% six-month retention. After 6-month intervention, average 24hr BP did not differ between the wine and water groups. The ABPM decreased in the red-wine group at midnight (3-4 hours after wine intake: systolic BP: red-wine=-10.6mmHg vs. mineral-water=+2.3mmHg; p=0.031) and the following morning at 7-9AM (systolic BP: red-wine:-6.2mmHg vs. mineral-water:+5.6mmHg; p=0.014). Among the red-wine consumers, only the individuals who were homozygous for the gene encoding ADH1B*2 variant (Arg48His;rs1229984,TT, fast ethanol metabolizers), exhibited a significant decrease in mean 24h systolic BP (-8.0mmHg vs. +3.7mmHg; p=0.002) and pulse pressure (-3.8mmHg vs. +1.2mmHg; p=0.032) compared to heterozygotes and homozygous for the ADH1B*1 variant (CC, slow metabolizers). No genetic interaction was observed for the water group.
Conclusions:Initiating moderate red-wine consumption at dinner in type-2-diabetics may have modest hypotensive effects within several hours after its consumption, and the following morning. The genetic interaction uncovers a personalized/precision-medicine factor regulating the hypotensive effect of red-wine in diabetes.
Original language | English |
---|---|
Article number | P802 |
Pages (from-to) | S179 |
Number of pages | 1 |
Journal | European Journal of Preventive Cardiology |
Volume | 22 |
Issue number | 1 |
DOIs | |
State | Published - 14 Jun 2015 |